Connect your AI

Vericel VCEL Total Liabilities & Equity

Total Liabilities & Equity at other companies

StrykerSYK

$46.29B+0.6%

Zimmer Biomet HoldingsZBH

$22.72B+2.4%

LeMaitre VascularLMAT

$629.53M+13.2%

Capricor TherapeuticsCAPR

$326.28M+112%

Globus MedicalGMED

$5.44B+15.5%

Johnson & JohnsonJNJ

$200.89B+3.7%

Other financials

Income statement

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Balance sheet

Cash & equivalents$109.3M+37.1%

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Cash flow

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Valuation

Market cap$2.13B-26.8%

Profitability

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Returns & leverage

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Vericel's total liabilities & equity?: Vericel (VCEL) reported total liabilities & equity of $485.63M in Q1 2026.
How has Vericel's total liabilities & equity changed year-over-year?: Vericel's total liabilities & equity increased by 14.4% year-over-year, from $424.59M to $485.63M.
What is the long-term trend for Vericel's total liabilities & equity?: Over 5 years (2020 to 2025), Vericel's total liabilities & equity has grown at a 18.9% compound annual growth rate (CAGR), from $205.61M to $487.97M.
What does total liabilities & equity mean?: Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.